Companies from French pharmaceutical giant Sanofi to US based Inovio Pharmaceuticals are beginning work toward a vaccine to combat Zika . Researchers are studying Zika s possible links to a surge in cases of microcephaly , a birth defect that causes babies to be born with abnormally small heads . The World Health Organization on Monday declared that the outbreak in Latin America is a public health emergency of international concern . Vaccines can take years to develop and countries are likely to have a long wait before there is an effective one against Zika .
